GlassScriptPhysician profile
Betsy Mccormick
NPI 1952482846
$1,265.14
in general payments reported to CMS, 2019-2025
10 companies · $425 in 2025
The $425 reported for 2025 was more than what 85% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $68.10 · 2022: $215 · 2023: $243 · 2024: $166 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $448.05 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $329.86 | 2022-2025 | Stripper, Origio Sequential Fert |
| Organon LLC | $257.18 | 2022-2025 | Follistim Aq, Ganirelix Acetate, Pregnyl |
| Abbvie INC. | $93.02 | 2019-2022 | |
| Myovant Sciences Gmbh | $49.44 | 2022 | |
| Merck Sharp & Dohme LLC | $19.77 | 2020 | |
| Hologic Sales and Service, LLC | $19.12 | 2024 | Myosure Tissue Removal Device |
| Gynesonics, INC. | $18.71 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $16.99 | 2022 | |
| Avion Pharmaceuticals | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Mccormick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.